Clinical trial
Study of Antitumor T Cell Immune Responses in Patients With Bladder Cancer
NCT06334406 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Antitumor T Cell Immune Responses in Patients With Bladder Cancer
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 2, 2024
- Completion date
- April 2, 2026
- Enrollment
- 33 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer